Literature DB >> 3152994

Renal handling of uric acid under cyclosporin A treatment.

P F Hoyer1, I J Lee, B S Oemar, H P Krohn, G Offner, J Brodehl.   

Abstract

The renal handling of uric acid during cyclosporin A (CyA) treatment was investigated by clearance studies using 24-h urine collections in 28 paediatric renal transplant recipients (CyA group), and the results were compared with those of 19 renal transplanted children treated with azathioprine and prednisolone (AZA group), 35 children with chronic renal failure (CRF) and 10 children with normal renal function (N group). Serum uric acid levels were significantly higher in the CyA group (567 +/- 156 mumol/l) compared with the AZA group (378 +/- 98), the CRF group (415 +/- 119) and the N group (290 +/- 68). Mean uric acid clearances in each group measured 3.9 +/- 2.8 ml/min per 1.73 m2 (CyA), 5.6 +/- 3.4 (AZA), 4.0 +/- 2.2 (CRF) and 8.4 +/- 3.7 (N). Calculation of the net tubular uric acid reabsorption per millilitre glomerular filtration rate revealed a significantly increased value of 0.53 +/- 0.15 mumol/ml in the CyA group (P less than 0.01) compared with 0.34 +/- 0.08, 0.29 +/- 0.15 and 0.27 +/- 0.07 mumol/l for the AZA, CRF and N groups respectively. We therefore conclude that CyA treatment is associated with an increased net tubular reabsorption of uric acid, which may lead to hyperuricaemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3152994     DOI: 10.1007/bf00870373

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

Review 1.  Hyperuricemia and gout. Classification, complications and management.

Authors:  G R Boss; J E Seegmiller
Journal:  N Engl J Med       Date:  1979-06-28       Impact factor: 91.245

2.  Fractional excretion of uric acid in infancy and childhood. Index of tubular maturation.

Authors:  J H Passwell; M Modan; M Brish; S Orda; H Boichis
Journal:  Arch Dis Child       Date:  1974-11       Impact factor: 3.791

3.  The effect of cyclosporine on organ blood flow.

Authors:  N McKenzie; R Devineni; W Vezina; P Keown; C Stiller
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

4.  Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.

Authors: 
Journal:  Clin Nephrol       Date:  1985-09       Impact factor: 0.975

5.  Cyclosporin A in pediatric kidney transplantation and its effect on posttransplantation growth.

Authors:  J Brodehl; G Offner; P F Hoyer; E Schirg; R Pichlmayr; K Wonigeit
Journal:  Nephron       Date:  1986       Impact factor: 2.847

6.  Renal function after kidney transplantation in children. A comparison of conventional immunosuppression with cyclosporine.

Authors:  P F Hoyer; H P Krohn; G Offner; D J Byrd; J Brodehl; K Wonigeit; R Pichlmayr
Journal:  Transplantation       Date:  1987-04       Impact factor: 4.939

7.  Cyclosporine: five years' experience in cadaveric renal transplantation.

Authors:  R M Merion; D J White; S Thiru; D B Evans; R Y Calne
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

8.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

9.  Use of cyclosporine in pediatric renal transplant recipients.

Authors:  S B Conley; S M Flechner; G Rose; C T Van Buren; E Brewer; B D Kahan
Journal:  J Pediatr       Date:  1985-01       Impact factor: 4.406

10.  A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245

View more
  8 in total

1.  Hyperuricemia and gout following pediatric renal transplantation.

Authors:  Giuseppina Spartà; Markus J Kemper; Thomas J Neuhaus
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

Review 2.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.

Authors:  Fernanda Cristina Mazali; Richard J Johnson; Marilda Mazzali
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

4.  Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.

Authors:  Severin Kengne-Wafo; Laura Massella; Francesca Diomedi-Camassei; Alessandra Gianviti; Marina Vivarelli; Marcella Greco; Gilda Rita Stringini; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 8.237

5.  Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  J Brodehl; M Brandis; U Helmchen; P F Hoyer; R Burghard; J H Ehrich; R B Zimmerhackl; W Klein; K Wonigeit
Journal:  Klin Wochenschr       Date:  1988-11-15

6.  Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption.

Authors:  P Heering; P Schadewaldt; D Bach; B Grabensee
Journal:  Clin Investig       Date:  1993-12

7.  Natural history and etiology of hyperuricemia following pediatric renal transplantation.

Authors:  V O Edvardsson; B A Kaiser; M S Polinsky; J A Palmer; R Quien; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

8.  Hyperuricemia beyond 1 year after kidney transplantation in pediatric patients: Prevalence and risk factors.

Authors:  B Einollahi; H Einollahi; Z Rostami
Journal:  Indian J Nephrol       Date:  2012-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.